Adam M. Thorne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adam M. Thorne has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Vincent E. de Meijer
Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
8 shared publications - Otto B. van Leeuwen
Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
4 shared publications - Robert J. Porte
Erasmus MC Transplant Institute, Department of Surgery, Division of HPB and Transplant Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands
4 shared publications - Silke B. Bodewes
Department of Surgery Division of HPB Surgery and Liver transplantation University of Groningen and University Medical Center Groningen Groningen the Netherlands
4 shared publications - Bianca Lascaris
Department of Surgery Division of HPB Surgery and Liver transplantation University of Groningen and University Medical Center Groningen Groningen the Netherlands
3 shared publications - Justina Clarinda Wolters
Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Wiley in Aging Cell
- Vol. 25 (11)
Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation
With an aging donor population, ischemic and inflammatory injury during organ procurement and preservation may be associated with senescence‐associated programs influencing graft biology. Although donor type‐specific injury patterns are known, their role in driving cellular senescence and downstream inflammatory responses remains unclear. We performed smart‐3SEQ bulk RNA‐sequencing on human liver tissue obtained from donation after brain death (DBD) and donation after circulatory death (DCD) donors. Senescence‐associated transcriptional signatures were assessed using the SenMayo gene panel and a liver‐specific senescence‐associated secretory phenotype panel. Immunohistochemistry assessed p16 and p21 protein expression. Findings were evaluated in NanoString‐based transcriptomic data from an external cohort. Sixty‐six livers (24 DBD and 42 DCD) were included. One thousand five hundredforty‐eight differentially expressed genes separated DBD and DCD grafts. Functional enrichment analysis showed distinct biological programs, with DBD grafts enriched for metabolic pathways, epithelial proliferation, and angiogenesis regulation, whereas DCD grafts showed enrichment of immune activation, chemokine signaling, and injury‐associated pathways. Senescence‐associated analyzes recapitulated this separation. Immunohistochemistry showed a higher proportion of p16‐positive nuclei in high‐risk DCD livers compared with DBD livers ( p = 0.038), whereas no significant difference was observed for p21 ( p = 0.687). However, tile‐level analysis showed significantly higher proportions of both p16‐ and p21‐positive nuclei in DCD livers ( p < 0.001). External cohort analysis confirmed donor‐type separation across available transcripts and senescence‐associated gene panels. Donor type reflects distinct transcriptional states in human donor livers, with senescence‐associated profiles overlapping with donor type‐specific injury responses. Injury‐induced senescence‐associated signaling may influence graft function and recipient (patho)physiology, positioning it as a promising modifiable senolytic or senomorphic target in liver transplantation.
- 11 November 2026
- Published by Wiley in Aging Cell
- Vol. 25 (11)
Open AccessTranscriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation
With an aging donor population, ischemic and inflammatory injury during organ procurement and preservation may be associated with senescence‐associated programs influencing graft biology. Although donor type‐specific injury patterns are known, their role in driving cellular senescence and downstream inflammatory responses remains unclear. We performed smart‐3SEQ bulk RNA‐sequencing on human liver tissue obtained from donation after brain death (DBD) and donation after circulatory death (DCD) donors. Senescence‐associated transcriptional signatures were assessed using the SenMayo gene panel and a liver‐specific senescence‐associated secretory phenotype panel. Immunohistochemistry assessed p16 and p21 protein expression. Findings were evaluated in NanoString‐based transcriptomic data from an external cohort. Sixty‐six livers (24 DBD and 42 DCD) were included. One thousand five hundredforty‐eight differentially expressed genes separated DBD and DCD grafts. Functional enrichment analysis showed distinct biological programs, with DBD grafts enriched for metabolic pathways, epithelial proliferation, and angiogenesis regulation, whereas DCD grafts showed enrichment of immune activation, chemokine signaling, and injury‐associated pathways. Senescence‐associated analyzes recapitulated this separation. Immunohistochemistry showed a higher proportion of p16‐positive nuclei in high‐risk DCD livers compared with DBD livers ( p = 0.038), whereas no significant difference was observed for p21 ( p = 0.687). However, tile‐level analysis showed significantly higher proportions of both p16‐ and p21‐positive nuclei in DCD livers ( p < 0.001). External cohort analysis confirmed donor‐type separation across available transcripts and senescence‐associated gene panels. Donor type reflects distinct transcriptional states in human donor livers, with senescence‐associated profiles overlapping with donor type‐specific injury responses. Injury‐induced senescence‐associated signaling may influence graft function and recipient (patho)physiology, positioning it as a promising modifiable senolytic or senomorphic target in liver transplantation.
- Open Access
- 20 February 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers
Glycogen Storage Disease (GSD) Types Ia and Ib are rare metabolic diseases caused by gene variants in G6PC1 and SLC37A4, respectively. Although life-threat
- 20 February 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessProteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers
Glycogen Storage Disease (GSD) Types Ia and Ib are rare metabolic diseases caused by gene variants in G6PC1 and SLC37A4, respectively. Although life-threat
- Open Access
Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers
Background: Glycogen Storage Disease (GSD) Types Ia and Ib are rare metabolic diseases caused by gene variants in G6PC1 and SLC37A4, respectively. Although life-threatening fasting hypoglycemia can be controlled by a strict diet, patients often suffer from multiple metabolic abnormalities and severe long-term complications. However, the underlying mechanisms remain incompletely understood, and the lack of effective monitoring biomarkers makes it a challenge to treat patients. Therefore, the aims of this study are to investigate the pathological mechanisms of the disease and disease complications in GSD I and identify potential protein biomarkers. Methods: In this study, we employed comprehensive untargeted proteomics on stored samples: 26 serum or plasma samples from 18 GSD Ia and 8 GSD Ib patients with 21 matched control sera, complemented by 4 liver samples from 2 GSD Ia patients who received liver transplantation (from the one patient with hepatocellular carcinoma we obtained tissue from both the carcinoma tissue and the adjacent non-carcinoma tissue), and 1 from a GSD Ib patient, compared to 10 donor liver samples. Results: We identified a total of 415 proteins in our analyses. Pathway analysis of the differentially regulated proteins revealed distinct changes in serum/plasma of GSD Ia and Ib. The coagulation pathway was the most significantly changed biological process in the GSD Ia patients. Immune response-associated proteins, especially a large number of immunoglobulins, were increased in GSD Ib specifically. Proteins related to liver injury, cholesterol, and amyloidosis were altered in two subtypes, though more pronounced in GSD Ia. Potential biomarkers with significant alterations both in the circulation as well as in the liver tissue were identified specifically for monitoring GSD I subtypes and prognosing liver deterioration, namely GSD Ia (COL163 and PROC), GSD Ib (F11 and CD163), and hepatocellular carcinoma (HCC) in GSD Ia patients (ALDOB and CFHR5). Conclusions: These findings provide new insights into the differences between the two GSD I subtypes and the pathogenesis of GSD I-related complications, as well as highlighting the potential of protein circulating biomarkers for monitoring complication progression in GSD I and assessing HCC risk in GSD Ia patients. Trial registration: Not applicable. A concise 1 sentence take-home message (synopsis) of the article: This comprehensive in-depth proteomics study on blood and liver GSD Ia and Ib patient samples provided novel insights into understanding of the disease subtypes as well as the the pathogenesis of GSD I-related complications, such as HCC risk in GSD Ia patients and identified potential biomarkers for the disease subtypes and complications.
Open AccessProteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers
Background: Glycogen Storage Disease (GSD) Types Ia and Ib are rare metabolic diseases caused by gene variants in G6PC1 and SLC37A4, respectively. Although life-threatening fasting hypoglycemia can be controlled by a strict diet, patients often suffer from multiple metabolic abnormalities and severe long-term complications. However, the underlying mechanisms remain incompletely understood, and the lack of effective monitoring biomarkers makes it a challenge to treat patients. Therefore, the aims of this study are to investigate the pathological mechanisms of the disease and disease complications in GSD I and identify potential protein biomarkers. Methods: In this study, we employed comprehensive untargeted proteomics on stored samples: 26 serum or plasma samples from 18 GSD Ia and 8 GSD Ib patients with 21 matched control sera, complemented by 4 liver samples from 2 GSD Ia patients who received liver transplantation (from the one patient with hepatocellular carcinoma we obtained tissue from both the carcinoma tissue and the adjacent non-carcinoma tissue), and 1 from a GSD Ib patient, compared to 10 donor liver samples. Results: We identified a total of 415 proteins in our analyses. Pathway analysis of the differentially regulated proteins revealed distinct changes in serum/plasma of GSD Ia and Ib. The coagulation pathway was the most significantly changed biological process in the GSD Ia patients. Immune response-associated proteins, especially a large number of immunoglobulins, were increased in GSD Ib specifically. Proteins related to liver injury, cholesterol, and amyloidosis were altered in two subtypes, though more pronounced in GSD Ia. Potential biomarkers with significant alterations both in the circulation as well as in the liver tissue were identified specifically for monitoring GSD I subtypes and prognosing liver deterioration, namely GSD Ia (COL163 and PROC), GSD Ib (F11 and CD163), and hepatocellular carcinoma (HCC) in GSD Ia patients (ALDOB and CFHR5). Conclusions: These findings provide new insights into the differences between the two GSD I subtypes and the pathogenesis of GSD I-related complications, as well as highlighting the potential of protein circulating biomarkers for monitoring complication progression in GSD I and assessing HCC risk in GSD Ia patients. Trial registration: Not applicable. A concise 1 sentence take-home message (synopsis) of the article: This comprehensive in-depth proteomics study on blood and liver GSD Ia and Ib patient samples provided novel insights into understanding of the disease subtypes as well as the the pathogenesis of GSD I-related complications, such as HCC risk in GSD Ia patients and identified potential biomarkers for the disease subtypes and complications.
- Open Access
- 25 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (8) , e70260
Transplantation of Severely Steatotic Liver Grafts After Machine Perfusion Remains a Risky Challenge
Liver transplantation is the treatment of choice for patients with end‐stage liver disease. However, donor shortages have increased the use of high‐risk and extended criteria donor livers, including livers donated after circulatory death and those with severe steatosis. Severe donor liver steatosis is associated with poor outcomes due to high susceptibility to ischemia‐reperfusion injury. Ex situ machine perfusion, combining hypothermic oxygenated perfusion and normothermic perfusion (termed the DHOPE‐COR‐NMP protocol), has emerged as a promising strategy to mitigate injury, assess liver viability, and improve transplant outcomes. Here, we present two patients who received very steatotic donor livers following resuscitation and viability assessment using DHOPE‐COR‐NMP. Although both steatotic donor liver functioned well during NMP and met all of our clinically validated viability criteria, the outcome after transplantation was complicated. One recipient suffered from pulmonary fat emboli syndrome, likely due to significant loss of fat from the donor liver. The second patient required retransplantation and histopathological examination of the donor liver revealed massive lipopeliosis in zones III of the explanted liver. With the increasing incidence of steatotic donor livers, further research to prevent steatosis‐related posttransplant complications is becoming progressively important. At present, transplantation of severely steatotic liver grafts remains a risky challenge, even after ex situ machine perfusion.
- 25 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (8) , e70260
Open AccessTransplantation of Severely Steatotic Liver Grafts After Machine Perfusion Remains a Risky Challenge
Liver transplantation is the treatment of choice for patients with end‐stage liver disease. However, donor shortages have increased the use of high‐risk and extended criteria donor livers, including livers donated after circulatory death and those with severe steatosis. Severe donor liver steatosis is associated with poor outcomes due to high susceptibility to ischemia‐reperfusion injury. Ex situ machine perfusion, combining hypothermic oxygenated perfusion and normothermic perfusion (termed the DHOPE‐COR‐NMP protocol), has emerged as a promising strategy to mitigate injury, assess liver viability, and improve transplant outcomes. Here, we present two patients who received very steatotic donor livers following resuscitation and viability assessment using DHOPE‐COR‐NMP. Although both steatotic donor liver functioned well during NMP and met all of our clinically validated viability criteria, the outcome after transplantation was complicated. One recipient suffered from pulmonary fat emboli syndrome, likely due to significant loss of fat from the donor liver. The second patient required retransplantation and histopathological examination of the donor liver revealed massive lipopeliosis in zones III of the explanted liver. With the increasing incidence of steatotic donor livers, further research to prevent steatosis‐related posttransplant complications is becoming progressively important. At present, transplantation of severely steatotic liver grafts remains a risky challenge, even after ex situ machine perfusion.
- Open Access
- 31 December 2024
- Published by Wiley in Artificial Organs
- Vol. 49 (5) , 820-830
Perfusion Pressures and Weight Loss During Normothermic Machine Perfusion of Human Donor Livers
Background: Normothermic machine perfusion (NMP) is increasingly used to preserve and assess donor livers prior to transplantation. Due to its success, it is expected that more centers will start using this technology. However, NMP may also cause adverse effects.Methods: In this retrospective, observational study, we investigated the effect of NMP pressures on donor liver weight, post‐transplant outcomes, and hepatic perfusion characteristics. A total of 36 livers were transplanted after NMP. NMP perfusion pressure settings were lowered from a median (IQR) of 47 mmHg (42–54) to 34 mmHg (30–39) for the hepatic artery (HA), and from 8 mmHg (7–10) to 7 mmHg (6–8) for the portal vein (PV) to diminish potential edema formation inside the liver.Results: This change appeared to lead to a reduction of liver weight after NMP (−22 g to −143 g, p = 0.02), without affecting the PV flow velocity (35.5 to 48.0 cm/s, p = 0.54), or hepatocellular injury markers during NMP (AST 1511–1148 U/L, p = 0.44; ALT 318–849 U/L, p = 0.35), and post‐transplantation outcomes. Changes in liver weight correlated significantly with the applied PV pressure during NMP (r = 0.52, p < 0.01) and the HA flow (r = 0.38, p < 0.05).Conclusion: NMP can lead to a reduction in liver weight, which might be masked by edema when high perfusion pressures are used. We encourage applying the lowest perfusion pressures possible to reach adequate flows and oxygen supply during liver NMP.
- 31 December 2024
- Published by Wiley in Artificial Organs
- Vol. 49 (5) , 820-830
Open AccessPerfusion Pressures and Weight Loss During Normothermic Machine Perfusion of Human Donor Livers
Background: Normothermic machine perfusion (NMP) is increasingly used to preserve and assess donor livers prior to transplantation. Due to its success, it is expected that more centers will start using this technology. However, NMP may also cause adverse effects.Methods: In this retrospective, observational study, we investigated the effect of NMP pressures on donor liver weight, post‐transplant outcomes, and hepatic perfusion characteristics. A total of 36 livers were transplanted after NMP. NMP perfusion pressure settings were lowered from a median (IQR) of 47 mmHg (42–54) to 34 mmHg (30–39) for the hepatic artery (HA), and from 8 mmHg (7–10) to 7 mmHg (6–8) for the portal vein (PV) to diminish potential edema formation inside the liver.Results: This change appeared to lead to a reduction of liver weight after NMP (−22 g to −143 g, p = 0.02), without affecting the PV flow velocity (35.5 to 48.0 cm/s, p = 0.54), or hepatocellular injury markers during NMP (AST 1511–1148 U/L, p = 0.44; ALT 318–849 U/L, p = 0.35), and post‐transplantation outcomes. Changes in liver weight correlated significantly with the applied PV pressure during NMP (r = 0.52, p < 0.01) and the HA flow (r = 0.38, p < 0.05).Conclusion: NMP can lead to a reduction in liver weight, which might be masked by edema when high perfusion pressures are used. We encourage applying the lowest perfusion pressures possible to reach adequate flows and oxygen supply during liver NMP.
- Open Access
- 30 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Bile proteome reveals biliary regeneration during normothermic preservation of human donor livers
Normothermic machine perfusion (NMP) after static cold storage is increasingly used for preservation and assessment of human donor livers prior to transplantation. Biliary viability assessment during NMP reduces the risk of post-transplant biliary complications. However, understanding of molecular changes in the biliary system during NMP remains incomplete. We performed an in-depth, unbiased proteomics analysis of bile collected during sequential hypothermic machine perfusion, rewarming and NMP of 55 human donor livers. Longitudinal analysis during NMP reveals proteins reflective of cellular damage at early stages, followed by upregulation of secretory and immune response processes. Livers with bile chemistry acceptable for transplantation reveal protein patterns implicated in regenerative processes, including cellular proliferation, compared to livers with inadequate bile chemistry. These findings are reinforced by detection of regenerative gene transcripts in liver tissue before machine perfusion. Our comprehensive bile proteomics and liver transcriptomics data sets provide the potential to further evaluate molecular mechanisms during NMP and refine viability assessment criteria.
- 30 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Open AccessBile proteome reveals biliary regeneration during normothermic preservation of human donor livers
Normothermic machine perfusion (NMP) after static cold storage is increasingly used for preservation and assessment of human donor livers prior to transplantation. Biliary viability assessment during NMP reduces the risk of post-transplant biliary complications. However, understanding of molecular changes in the biliary system during NMP remains incomplete. We performed an in-depth, unbiased proteomics analysis of bile collected during sequential hypothermic machine perfusion, rewarming and NMP of 55 human donor livers. Longitudinal analysis during NMP reveals proteins reflective of cellular damage at early stages, followed by upregulation of secretory and immune response processes. Livers with bile chemistry acceptable for transplantation reveal protein patterns implicated in regenerative processes, including cellular proliferation, compared to livers with inadequate bile chemistry. These findings are reinforced by detection of regenerative gene transcripts in liver tissue before machine perfusion. Our comprehensive bile proteomics and liver transcriptomics data sets provide the potential to further evaluate molecular mechanisms during NMP and refine viability assessment criteria.
- Top Cited PapersOpen Access
- 18 April 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (6) , 1658-1670
Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers
- 18 April 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (6) , 1658-1670
Top Cited PapersOpen AccessSequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers
- Open Access
- 6 December 2021
- Published by Wiley in Artificial Organs
- Vol. 46 (2) , 201-209
Oxygenated versus non‐oxygenated flush out and storage of donor livers: An experimental study
Background During donor organ procurement and subsequent static cold storage (SCS), hepatic adenosine triphosphate (ATP) levels are progressively depleted, which contributes to ischemia-reperfusion injury (IRI). We sought to investigate a simple approach to prevent ATP depletion and IRI using a porcine donation after circulatory death (DCD) liver reperfusion model. Methods After 30 min warm ischemia, porcine livers were flushed via the portal vein with cold (4°C) non-oxygenated University of Wisconsin (UW) preservation solution (n=6, control group) or with oxygenated UW (n=6, OxyFlush group). Livers were then subjected to 4 hr SCS in non-oxygenated (control) or oxygenated (OxyFlush) UW, followed by 4 hr normothermic reperfusion using whole blood. Hepatic ATP levels were compared and hepatobiliary function and injury were assessed. Results At the end of SCS, ATP was higher in the OxyFlush group compared to controls (delta ATP of +0.26 vs. -0.68 µmol/g protein, P=0.04). All livers produced bile and metabolized lactate, and there were no differences between the groups. Grafts in the OxyFlush group had lower blood glucose levels after reperfusion (P=0.04). Biliary pH, glucose and bicarbonate were not different between the groups. Injury markers including liver transaminases, lactate dehydrogenase, malondialdehyde, cell-free DNA and flavin mononucleotide in the SCS solution and during reperfusion were also similar. Histological assessment of the parenchyma and bile ducts did not reveal differences between the groups. Conclusion Oxygenated flush out and storage of DCD porcine livers prevents ATP depletion during ischemia, but this does not seem sufficient to mitigate early signs of IRI.
- 6 December 2021
- Published by Wiley in Artificial Organs
- Vol. 46 (2) , 201-209
Open AccessOxygenated versus non‐oxygenated flush out and storage of donor livers: An experimental study
Background During donor organ procurement and subsequent static cold storage (SCS), hepatic adenosine triphosphate (ATP) levels are progressively depleted, which contributes to ischemia-reperfusion injury (IRI). We sought to investigate a simple approach to prevent ATP depletion and IRI using a porcine donation after circulatory death (DCD) liver reperfusion model. Methods After 30 min warm ischemia, porcine livers were flushed via the portal vein with cold (4°C) non-oxygenated University of Wisconsin (UW) preservation solution (n=6, control group) or with oxygenated UW (n=6, OxyFlush group). Livers were then subjected to 4 hr SCS in non-oxygenated (control) or oxygenated (OxyFlush) UW, followed by 4 hr normothermic reperfusion using whole blood. Hepatic ATP levels were compared and hepatobiliary function and injury were assessed. Results At the end of SCS, ATP was higher in the OxyFlush group compared to controls (delta ATP of +0.26 vs. -0.68 µmol/g protein, P=0.04). All livers produced bile and metabolized lactate, and there were no differences between the groups. Grafts in the OxyFlush group had lower blood glucose levels after reperfusion (P=0.04). Biliary pH, glucose and bicarbonate were not different between the groups. Injury markers including liver transaminases, lactate dehydrogenase, malondialdehyde, cell-free DNA and flavin mononucleotide in the SCS solution and during reperfusion were also similar. Histological assessment of the parenchyma and bile ducts did not reveal differences between the groups. Conclusion Oxygenated flush out and storage of DCD porcine livers prevents ATP depletion during ischemia, but this does not seem sufficient to mitigate early signs of IRI.
- Open Access
- 26 August 2021
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (9) , 1618-1629
Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1‐year outcome
Assessment of donor kidney quality is based on clinical scores or requires biopsies for histological assessment. Noninvasive strategies to identify and predict graft outcome at an early stage are, therefore, needed. We evaluated the perfusate of donation after brain death (DBD) kidneys during nonoxygenated hypothermic machine perfusion (HMP). In particular, we compared perfusate protein profiles of good outcome (GO) and suboptimal outcome (SO) 1-year post-transplantation. Samples taken 15 min after the start HMP (T1) and before the termination of HMP (T2) were analysed using quantitative liquid chromatography–tandem mass spectrometry (LC-MS/MS). Hierarchical clustering of the 100 most abundant proteins showed discrimination between grafts with a GO and SO at T1. Elevated levels of proteins involved in classical complement cascades at both T1 and T2 and a reduced abundance of lipid metabolism at T1 and of cytoskeletal proteins at T2 in GO versus SO was observed. ATP-citrate synthase and fatty acid-binding protein 5 (T1) and immunoglobulin heavy variable 2-26 and desmoplakin (T2) showed 91% and 86% predictive values, respectively, for transplant outcome. Taken together, DBD kidney HMP perfusate profiles can distinguish between outcome 1-year post-transplantation. Furthermore, it provides insights into mechanisms that could play a role in post-transplant outcomes.
- 26 August 2021
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (9) , 1618-1629
Open AccessProteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1‐year outcome
Assessment of donor kidney quality is based on clinical scores or requires biopsies for histological assessment. Noninvasive strategies to identify and predict graft outcome at an early stage are, therefore, needed. We evaluated the perfusate of donation after brain death (DBD) kidneys during nonoxygenated hypothermic machine perfusion (HMP). In particular, we compared perfusate protein profiles of good outcome (GO) and suboptimal outcome (SO) 1-year post-transplantation. Samples taken 15 min after the start HMP (T1) and before the termination of HMP (T2) were analysed using quantitative liquid chromatography–tandem mass spectrometry (LC-MS/MS). Hierarchical clustering of the 100 most abundant proteins showed discrimination between grafts with a GO and SO at T1. Elevated levels of proteins involved in classical complement cascades at both T1 and T2 and a reduced abundance of lipid metabolism at T1 and of cytoskeletal proteins at T2 in GO versus SO was observed. ATP-citrate synthase and fatty acid-binding protein 5 (T1) and immunoglobulin heavy variable 2-26 and desmoplakin (T2) showed 91% and 86% predictive values, respectively, for transplant outcome. Taken together, DBD kidney HMP perfusate profiles can distinguish between outcome 1-year post-transplantation. Furthermore, it provides insights into mechanisms that could play a role in post-transplant outcomes.